S&P 500   4,234.48 (-1.26%)
DOW   33,062.25 (-1.11%)
QQQ   355.95 (-1.47%)
AAPL   172.18 (-0.90%)
MSFT   313.64 (-2.54%)
META   301.04 (-1.88%)
GOOGL   132.79 (-1.03%)
AMZN   125.50 (-3.06%)
TSLA   249.01 (-1.03%)
NVDA   439.28 (-1.91%)
NIO   8.72 (-0.80%)
BABA   84.84 (-1.95%)
AMD   100.83 (-2.36%)
T   14.61 (-0.41%)
F   12.13 (-1.46%)
MU   68.60 (+0.94%)
CGC   0.70 (-5.09%)
GE   107.86 (-0.85%)
DIS   79.84 (-2.24%)
AMC   8.00 (-1.84%)
PFE   33.88 (-0.18%)
PYPL   57.77 (-1.35%)
NFLX   378.96 (-0.36%)
S&P 500   4,234.48 (-1.26%)
DOW   33,062.25 (-1.11%)
QQQ   355.95 (-1.47%)
AAPL   172.18 (-0.90%)
MSFT   313.64 (-2.54%)
META   301.04 (-1.88%)
GOOGL   132.79 (-1.03%)
AMZN   125.50 (-3.06%)
TSLA   249.01 (-1.03%)
NVDA   439.28 (-1.91%)
NIO   8.72 (-0.80%)
BABA   84.84 (-1.95%)
AMD   100.83 (-2.36%)
T   14.61 (-0.41%)
F   12.13 (-1.46%)
MU   68.60 (+0.94%)
CGC   0.70 (-5.09%)
GE   107.86 (-0.85%)
DIS   79.84 (-2.24%)
AMC   8.00 (-1.84%)
PFE   33.88 (-0.18%)
PYPL   57.77 (-1.35%)
NFLX   378.96 (-0.36%)
S&P 500   4,234.48 (-1.26%)
DOW   33,062.25 (-1.11%)
QQQ   355.95 (-1.47%)
AAPL   172.18 (-0.90%)
MSFT   313.64 (-2.54%)
META   301.04 (-1.88%)
GOOGL   132.79 (-1.03%)
AMZN   125.50 (-3.06%)
TSLA   249.01 (-1.03%)
NVDA   439.28 (-1.91%)
NIO   8.72 (-0.80%)
BABA   84.84 (-1.95%)
AMD   100.83 (-2.36%)
T   14.61 (-0.41%)
F   12.13 (-1.46%)
MU   68.60 (+0.94%)
CGC   0.70 (-5.09%)
GE   107.86 (-0.85%)
DIS   79.84 (-2.24%)
AMC   8.00 (-1.84%)
PFE   33.88 (-0.18%)
PYPL   57.77 (-1.35%)
NFLX   378.96 (-0.36%)
S&P 500   4,234.48 (-1.26%)
DOW   33,062.25 (-1.11%)
QQQ   355.95 (-1.47%)
AAPL   172.18 (-0.90%)
MSFT   313.64 (-2.54%)
META   301.04 (-1.88%)
GOOGL   132.79 (-1.03%)
AMZN   125.50 (-3.06%)
TSLA   249.01 (-1.03%)
NVDA   439.28 (-1.91%)
NIO   8.72 (-0.80%)
BABA   84.84 (-1.95%)
AMD   100.83 (-2.36%)
T   14.61 (-0.41%)
F   12.13 (-1.46%)
MU   68.60 (+0.94%)
CGC   0.70 (-5.09%)
GE   107.86 (-0.85%)
DIS   79.84 (-2.24%)
AMC   8.00 (-1.84%)
PFE   33.88 (-0.18%)
PYPL   57.77 (-1.35%)
NFLX   378.96 (-0.36%)
NASDAQ:ELDN

Eledon Pharmaceuticals (ELDN) Earnings Date, Estimates & Call Transcripts

$1.46
-0.09 (-5.81%)
(As of 12:00 PM ET)
Compare
Today's Range
$1.40
▼
$1.60
50-Day Range
$1.14
▼
$1.66
52-Week Range
$1.08
▼
$3.70
Volume
44,808 shs
Average Volume
96,879 shs
Market Capitalization
$34.38 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$9.50
ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media

Earnings Summary

Upcoming
Earnings Date
Nov. 13Estimated
Actual EPS
(Aug. 10)
-$0.40 Beat By $0.07
Consensus EPS
(Aug. 10)
-$0.47
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

ELDN Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ELDN Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Eledon Pharmaceuticals Analyst Forecasts

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20231($0.71)($0.71)($0.71)
Q2 20232($0.48)($0.47)($0.48)
Q3 20231($0.37)($0.37)($0.37)
Q4 20231($0.38)($0.38)($0.38)
FY 20235($1.94)($1.93)($1.94)

ELDN Earnings Date and Information

Eledon Pharmaceuticals last announced its quarterly earnings data on August 10th, 2023. The reported ($0.40) EPS for the quarter, beating the consensus estimate of ($0.47) by $0.07. Eledon Pharmaceuticals has generated ($5.97) earnings per share over the last year (($5.97) diluted earnings per share). Earnings for Eledon Pharmaceuticals are expected to grow in the coming year, from ($1.95) to ($1.39) per share. Eledon Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 13th, 2023 based off prior year's report dates.

Eledon Pharmaceuticals Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
11/13/2023
Estimated)		------- 
8/10/2023Q2 2023($0.47)($0.40)+$0.07($0.40)--
5/11/2023Q1 2023($0.71)($0.75)($0.04)($0.75)--
3/30/2023Q4 2022($0.70)($0.68)+$0.02$2.73--
11/14/2022Q3 2022($0.68)($0.73)($0.05)($0.73)--
8/11/2022Q2 2022($0.72)($0.65)+$0.07($0.65)--
5/12/2022Q1 2022($0.67)($0.69)($0.02)($0.69)--
3/24/2022Q4 2021($0.83)($0.59)+$0.24($0.59)--    
11/11/2021Q3 2021($0.67)($0.66)+$0.01($0.66)--    
8/12/2021Q2 2021($0.58)($0.50)+$0.08($0.50)--    
5/13/2021Q1 2021($0.37)($0.57)($0.20)($0.57)--  
11/16/2020Q3 2020($1.64)($3.91)($2.27)($2.31)--












Eledon Pharmaceuticals Earnings - Frequently Asked Questions

When is Eledon Pharmaceuticals's earnings date?

Eledon Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 13th, 2023 based off last year's report dates. Learn more on ELDN's earnings history.

Did Eledon Pharmaceuticals beat their earnings estimates last quarter?

In the previous quarter, Eledon Pharmaceuticals (NASDAQ:ELDN) reported ($0.40) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.47) by $0.07. Learn more on analysts' earnings estimate vs. ELDN's actual earnings.

How much profit does Eledon Pharmaceuticals generate each year?

Eledon Pharmaceuticals (NASDAQ:ELDN) has a recorded net income of -$87.97 million. ELDN has generated -$5.97 earnings per share over the last four quarters.

What is Eledon Pharmaceuticals's EPS forecast for next year?

Eledon Pharmaceuticals's earnings are expected to grow from ($1.95) per share to ($1.39) per share in the next year.


More Earnings Resources from MarketBeat

Related Companies:
Earnings Tools:
Earnings By Country:
Latest Articles:
This page (NASDAQ:ELDN) was last updated on 10/3/2023 by MarketBeat.com Staff

My Account -